Trials / Conditions / Recurrent WHO Grade 4 Glioma
Recurrent WHO Grade 4 Glioma
5 registered clinical trials studyying Recurrent WHO Grade 4 Glioma — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patie NCT07422363 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas NCT06964737 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Recruiting | Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma NCT06160206 | Academic and Community Cancer Research United | Phase 2 |
| Active Not Recruiting | Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma NCT06410248 | Northwestern University | Phase 1 |
| Recruiting | Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatmen NCT05859334 | National Cancer Institute (NCI) | Phase 2 |